28088901|t|Advanced Structure-activity Relationships Applied to Mentha spicata L. Subsp. spicata Essential Oil Compounds as AChE and NMDA Ligands, in Comparison with Donepezil, Galantamine and Memantine - New Approach in Brain Disorders Pharmacology.
28088901|a|BACKGROUND: Alzheimer's disease (AD) therapy is based on several natural and synthetic compounds that act as acetylcholinesterase (AChE) and N-methyl-D-aspartate receptor (NMDA) ligands that have limited efficiency in relieving AD symptoms. Recent studies show that inhibitors isolated from Mentha spicata L. subsp. spicata are promising for AD therapy. OBJECTIVE: We aimed to identify novel and more potent phytopharmaceutical compounds for AD treatment by taking into account the compounds from Mentha spicata L. subsp. spicata essential oil. METHOD: We generated structure-activity relationship (SAR) models that predict the biological activities of 14 Mentha spicata L. subsp. spicata compounds on AChE and NMDA by comparing their molecular features with those of the three conventional ligands: donepezil, galantamine and memantine. RESULTS: The most relevant descriptors for predicting the biological activities of considered compounds are solvent accessible area and their subdivided, hydrophobicity, energy of frontier molecular orbitals and counts of the aromatic ring and rotatable bounds. 1,8-cineole, the main compound from Mentha spicata L. subsp. spicata essential oil, resulted to be similar with memantine and dissimilar with donepezil in respect to hidrophobicity (logP1,8-cineole=2.95, logPmemantine=2.81, logPdonepezil=4.11), the energy of LUMO (eLUMO1,8-cineole=3.01 eV, eLUMOmemantine=3.35 eV, eLUMOdonepezil=-0.35 eV) and the solvent accessible surface areas over all hydrophobic (SA_H1,8-cineole= 350 A2, SA_Hmemantine= 358 A2, SA_Hdonepezil= 655 A2) or polar atoms (SA_P1,8-cineole= 4 A2, SA_Pmemantine=10 A2, SA_Pdonepezil=44.62 A2). CONCLUSION: Our results point towards 1,8-cineole as a good candidate for NMDA antagonism, with a weaker AChE inhibitory effect. Our results may be useful in establishing new therapeutic strategies for neurological disorders.
28088901	53	77	Mentha spicata L. Subsp.	Species	
28088901	78	99	spicata Essential Oil	Chemical	-
28088901	155	164	Donepezil	Chemical	MESH:D000077265
28088901	166	177	Galantamine	Chemical	MESH:D005702
28088901	182	191	Memantine	Chemical	MESH:D008559
28088901	210	225	Brain Disorders	Disease	MESH:D001927
28088901	252	271	Alzheimer's disease	Disease	MESH:D000544
28088901	273	275	AD	Disease	MESH:D000544
28088901	468	470	AD	Disease	MESH:D000544
28088901	531	555	Mentha spicata L. subsp.	Species	
28088901	556	563	spicata	Disease	
28088901	582	584	AD	Disease	MESH:D000544
28088901	682	684	AD	Disease	MESH:D000544
28088901	737	761	Mentha spicata L. subsp.	Species	
28088901	762	783	spicata essential oil	Chemical	-
28088901	896	920	Mentha spicata L. subsp.	Species	
28088901	921	928	spicata	Chemical	-
28088901	1040	1049	donepezil	Chemical	MESH:D000077265
28088901	1051	1062	galantamine	Chemical	MESH:D005702
28088901	1067	1076	memantine	Chemical	MESH:D008559
28088901	1340	1351	1,8-cineole	Chemical	MESH:D000077591
28088901	1376	1400	Mentha spicata L. subsp.	Species	
28088901	1401	1422	spicata essential oil	Chemical	-
28088901	1452	1461	memantine	Chemical	MESH:D008559
28088901	1482	1491	donepezil	Chemical	MESH:D000077265
28088901	1529	1537	-cineole	Chemical	MESH:D000077591
28088901	1605	1621	eLUMO1,8-cineole	Chemical	-
28088901	1631	1645	eLUMOmemantine	Chemical	-
28088901	1655	1669	eLUMOdonepezil	Chemical	-
28088901	1743	1745	SA	Chemical	MESH:D000077145
28088901	1746	1758	H1,8-cineole	Chemical	-
28088901	1768	1770	SA	Chemical	MESH:D000077145
28088901	1771	1781	Hmemantine	Chemical	-
28088901	1791	1793	SA	Chemical	MESH:D000077145
28088901	1794	1804	Hdonepezil	Chemical	-
28088901	1830	1832	SA	Chemical	MESH:D000077145
28088901	1837	1845	-cineole	Chemical	MESH:D000077591
28088901	1853	1855	SA	Chemical	MESH:D000077145
28088901	1874	1876	SA	Chemical	MESH:D000077145
28088901	1877	1887	Pdonepezil	Chemical	-
28088901	1937	1948	1,8-cineole	Chemical	MESH:D000077591
28088901	2101	2123	neurological disorders	Disease	MESH:D009461
28088901	Negative_Correlation	MESH:D008559	MESH:D000544
28088901	Association	MESH:D005702	MESH:D001927
28088901	Association	MESH:D000077265	MESH:D000077591
28088901	Comparison	MESH:D000077591	MESH:D008559
28088901	Association	MESH:D008559	MESH:D001927
28088901	Association	MESH:D000077265	MESH:D001927

